comparison of loratadine and cetirizine in perennial allergic rhinitis
نویسندگان
چکیده
background: allergic rhinitis (ar) represents a global health problem, affecting 5-50% of the population worldwide and numerous classes of pharmacological agents are available for its treatment. two more popular of these drugs are loratadine and cetirizine. there are few direct comparator studies between these two drugs with inconsistent results. m aterials and methods: a randomized, double-blind study for comparison the therapeutic effects of loratadine and cetirizine was conducted in an otolaryngologic clinic of a general hospital. eighty patients with perennial allergic rhinitis were divided into two equal groups. one group received loratadine 10 mg daily for two weeks and the other group cetirizine 10 mg daily also for two weeks. alterations of the allergic rhinitis symptoms including rhinorrhea, sneezing, nasal itching and nasal obstruction were compared between the two groups. r es ults: severity of all four studied symptoms was reduced by both drugs. although cetirizine had a little more efficacy, their difference was not statistically significant (p>0.05). these two medications were most effective in reducing the sneezing and least effective on the nasal obstruction. c onclusion: loratadine and cetirizine can reduce symptoms of the perennialallergic rhinitis but their difference is not statistically significant.
منابع مشابه
Perennial allergic rhinitis and keratoconjunctivitis.
There are many studies dedicated to the allergic nose, but most of them deal with seasonal allergic rhinitis and particularly with acute experimental situations. Perennial allergic rhinitis is less well documented. When studying the allergic nose, several aspects must be taken into consideration: the genetic background of the patient, various environmental factors (antigens, air pollution, clim...
متن کاملlaratadine in perennial allergic rhinitis
ylline pharmacokinetics. Clin Pharmacol Ther 1988;43: 147. 24. Conrad KA, Nymaa DW. Effects of metoprolol and propran0101 on theopbylline elimination. Clin Pharmacol Ther 1980; 28~463-7. 25. Cusack BJ, Dawson GW, Mercer GD, Vestal RE. Cigarette smoking and theophylline metabolism: effects of cimetidine. Clin Pharmacol Ther 1985:37:330-6. 26. Richer C, Mathieu M, Bah H, et al. Theophylline kinet...
متن کامل[Loratadine in the treatment of seasonal allergic rhinitis].
A single blind, placebo-controlled, parallel-group study was performed during a pollen season in 41 patients suffering from seasonal allergic rhinitis. A group of 26 patients was treated with loratadine (10 mg daily in one dose) for 3 weeks. Placebo was given in the group of 15 patients (1 tablet daily) during 8-10 days. The following parameters were assessed: clinical symptoms (rhinorhea, snee...
متن کاملClinical Efficacy and Safety of a Combined Loratadine-Betamethasone Oral Solution in the Treatment of Severe Pediatric Perennial Allergic Rhinitis
BACKGROUND : Allergic rhinitis is a highly prevalent condition, particularly among children, whose schoolwork and quality of life may be impaired by its symptoms. METHODS : In this prospective, multicenter study, children between 6 and 12 years old with a diagnosis of severe perennial allergic rhinitis received a combination of the nonsedating antihistamine loratadine and the corticosteroid b...
متن کاملNatural treatment of perennial allergic rhinitis.
Perennial allergic rhinitis is an IgE-mediated inflammatory disorder of the nasal mucosa characterized by paroxysms of sneezing, nasal congestion, pruritus, and rhinorrhea. The condition may be caused by certain environmental agents, food sensitivities, structural abnormalities, metabolic conditions, or synthetic drugs. Recent health impairment outcome studies on allergic rhinitis sufferers rev...
متن کاملEvaluation of SubcutaneousRush Immunotherapy Effectiveness in Perennial Allergic Rhinitis after a Year from Treatment
Introduction: Allergen immunotherapy is an effective treatment for allergic rhinitis. Conventional immunotherapy takesat least 5 to 6 months to reach the maintenance dosage; nonetheless, rush immunotherapy accelerates to reach the maintenance dose several months earlier. However, the safety and efficacy of this treatment has not been widely investigated. The objective of the present study...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
novelty in biomedicineجلد ۳، شماره ۳، صفحات ۱۳۵-۱۳۹
کلمات کلیدی
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023